Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Jun 28 PTGX Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Jun 28 NVO Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Jun 28 PTGX Protagonist Therapeutics set to join S&P SmallCap 600
Jun 27 NVO Novo Nordisk (NVO) Rises Higher Than Market: Key Facts
Jun 27 PTGX Protagonist Therapeutics Set to Join S&P SmallCap 600
Jun 27 ALNY Peering Into Alnylam Pharmaceuticals's Recent Short Interest
Jun 27 PTGX Is Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
Jun 27 ALNY Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Jun 27 NVO Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
Jun 27 NVO 2seventy bio completes $40m haemophilia A program deal with Novo Nordisk
Jun 27 NVO Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
Jun 27 NVO European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk
Jun 27 NVO Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot
Jun 27 NVO Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
Jun 27 NVO Walgreens cuts EPS guidance, plans to close more stores
Jun 27 NVO Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal
Jun 27 HALO Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Jun 27 NVO Market Chatter: Novo Nordisk to Limit Launch of Wegovy in China, Executive Says
Jun 27 NVO 2seventy slims down with sale of hemophilia assets to Novo
Jun 27 NVO Novo reportedly eyeing a limited launch of Wegovy in China
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags